Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001628280-25-004708

Chief Executive Officer acquired 9,550 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Anzalone Christopher Richard Chief Executive Officer 2025-02-07 Grant or award +9,550 $20.10 $191,955 3,773,802 D
Loading xslF345X05/wk-form4_1739229790.xml…